Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Double Dummy, Active Comparator, Parallel Group, Multicenter Study to Evaluate the Safety of Once-Daily Fluticasone Furoate/GW642444 Inhalation Powder for 52 Weeks in Adolescent and Adult Subjects With Asthma
Brief Summary: The purpose of this study is to evaluate the long-term safety of fluticasone furoate/GW642444


Options:
A: Arm Label: Fluticasone furoate/GW642444; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Furoate/GW642444 | Arm Label: Fluticasone propionate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone propionate | Intervention Type: DRUG; Name: Fluticasone Furoate/GW642444; Assigned to Arm(s): Fluticasone furoate/GW642444 | Intervention Type: DRUG; Name: Fluticasone propionate; Assigned to Arm(s): Fluticasone propionate
B: Arm Label: Tiotropium Respimat (low dose); Type: EXPERIMENTAL; Interventions: Drug: Tiotropium Respimat | Arm Label: Tiotropium Respimat (high dose); Type: EXPERIMENTAL; Interventions: Drug: Tiotropium Respimat | Arm Label: Placebo Respimat; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Respimat | Intervention Type: DRUG; Name: Tiotropium Respimat; Assigned to Arm(s): Tiotropium Respimat (high dose) | Intervention Type: DRUG; Name: Placebo Respimat; Assigned to Arm(s): Placebo Respimat | Intervention Type: DRUG; Name: Tiotropium Respimat; Assigned to Arm(s): Tiotropium Respimat (low dose)
C: Arm Label: MF/F MDI 400/10 mcg BID; Type: EXPERIMENTAL; Interventions: Drug: Mometasone furoate/formoterol (MF/F) combination | Arm Label: MF/F MDI 200/10 mcg BID; Type: EXPERIMENTAL; Interventions: Drug: Mometasone furoate/formoterol (MF/F) combination | Arm Label: MF MDI 400 mcg BID; Type: EXPERIMENTAL; Interventions: Drug: Mometasone furoate MDI (MF MDI) | Arm Label: Formoterol MDI 10 mcg BID; Type: ACTIVE_COMPARATOR; Interventions: Drug: Formoterol MDI | Arm Label: Placebo MDI BID; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Mometasone furoate/formoterol (MF/F) combination; Assigned to Arm(s): MF/F MDI 400/10 mcg BID | Intervention Type: DRUG; Name: Mometasone furoate/formoterol (MF/F) combination; Assigned to Arm(s): MF/F MDI 200/10 mcg BID | Intervention Type: DRUG; Name: Mometasone furoate MDI (MF MDI); Assigned to Arm(s): MF MDI 400 mcg BID | Intervention Type: DRUG; Name: Formoterol MDI; Assigned to Arm(s): Formoterol MDI 10 mcg BID | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo MDI BID
D: Arm Label: MF/F 200/10 mcg BID; Type: EXPERIMENTAL; Interventions: Drug: mometasone furoate combination MDI 200/10 mcg BID | Arm Label: MF/F 400/10 mcg BID; Type: EXPERIMENTAL; Interventions: Drug: mometasone furoate combination MDI 400/10 mcg BID | Arm Label: F/SC 250/50 mcg BID; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone/Salmeterol 250/50 mcg BID | Arm Label: F/SC 500/50 mcg BID; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone/Salmeterol 500/50 mcg BID | Intervention Type: DRUG; Name: mometasone furoate combination MDI 200/10 mcg BID; Assigned to Arm(s): MF/F 200/10 mcg BID | Intervention Type: DRUG; Name: mometasone furoate combination MDI 400/10 mcg BID; Assigned to Arm(s): MF/F 400/10 mcg BID | Intervention Type: DRUG; Name: Fluticasone/Salmeterol 250/50 mcg BID; Assigned to Arm(s): F/SC 250/50 mcg BID | Intervention Type: DRUG; Name: Fluticasone/Salmeterol 500/50 mcg BID; Assigned to Arm(s): F/SC 500/50 mcg BID

Answer: A